Kyle Bauser

Stock Analyst at Roth Capital

(3.88)
# 613
Out of 5,163 analysts
30
Total ratings
55.56%
Success rate
10.62%
Average return

Stocks Rated by Kyle Bauser

LeMaitre Vascular
Feb 26, 2026
Reiterates: Buy
Price Target: $108$117
Current: $108.06
Upside: +8.27%
InfuSystem Holdings
Feb 25, 2026
Reiterates: Buy
Price Target: $14$15
Current: $9.31
Upside: +61.12%
Tactile Systems Technology
Feb 18, 2026
Maintains: Neutral
Price Target: $16$32
Current: $26.93
Upside: +18.83%
Apyx Medical
Dec 16, 2025
Initiates: Buy
Price Target: $6
Current: $3.63
Upside: +65.29%
Microbot Medical
Dec 3, 2025
Initiates: Buy
Price Target: $5.5
Current: $2.69
Upside: +104.46%
Electromed
Nov 13, 2025
Reiterates: Buy
Price Target: $35$36
Current: $23.51
Upside: +53.13%
Stereotaxis
Nov 12, 2025
Reiterates: Buy
Price Target: $4
Current: $1.89
Upside: +111.64%
SANUWAVE Health
Aug 22, 2025
Maintains: Buy
Price Target: $54$55
Current: $21.52
Upside: +155.64%
Varex Imaging
Aug 8, 2025
Maintains: Buy
Price Target: $12$16
Current: $10.81
Upside: +48.01%
Bio-Techne
Jul 9, 2025
Initiates: Buy
Price Target: $65
Current: $50.85
Upside: +27.83%
Initiates: Neutral
Price Target: $15
Current: $11.78
Upside: +27.33%
Initiates: Buy
Price Target: $15
Current: $4.20
Upside: +257.14%
Initiates: Buy
Price Target: n/a
Current: $203.87
Upside: -